A Cobos, M Valerio, M Palomo, I Adán, P Catalán, C Veintimilla, F López-Andújar, C Rincón, A Galar, R Alonso, M Machado, P Gijón, T Aldámiz-Echevarría Lois, L Pérez Latorre, C Diez, C Fanciulli, E Bouza Santiago, P Muñoz
{"title":"Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak.","authors":"A Cobos, M Valerio, M Palomo, I Adán, P Catalán, C Veintimilla, F López-Andújar, C Rincón, A Galar, R Alonso, M Machado, P Gijón, T Aldámiz-Echevarría Lois, L Pérez Latorre, C Diez, C Fanciulli, E Bouza Santiago, P Muñoz","doi":"10.37201/req/112.2022","DOIUrl":"10.37201/req/112.2022","url":null,"abstract":"<p><p>The present outbreak of Human Monkeypox (HMPX) that has begun in May 2022 and has spread across all continents in less than two months has qualitative and quantitative characteristics that make it different from the pattern of human disease previously caused by this virus. It has spread with enormous ease, affects almost exclusively adults, behaves as a sexually transmitted disease and focuses on very specific groups and transmission conditions. The high incidence in the city of Madrid in males that have sex with males (MSM) has allowed us to observe and report the experience with the first 30 cases diagnosed in our institution. Patients presented with febrile symptoms, genital and paragenital skin lesions reminiscent of smallpox, but less extensive and severe. The disease may also cause proctitis, pharyngitis and perioral lesions. The PCR test for diagnostic confirmation has been shown to be very sensitive and effective, not only in skin lesions but also in blood and other fluids such as pharyngeal, rectal exudates and blood. A very high proportion of patients with HMPX also have other sexually transmitted diseases that must be actively detected in this context. The spontaneous evolution of our patients has been good and hospitalization has been practically unnecessary. Transmission to non-sexual cohabitants and health personnel has been nonexistent and the lesions have disappeared in less than 30 days without leaving sequelae and no need for specific antiviral treatment.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/26/revespquimioter-36-194.PMC10066919.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9237583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D Fernández Vecilla, I Angulo López, F E Calvo Muro, C Aspichueta Vivanco, F Renzi, M E Pereda Martínez, J Rosselló Soria, J L Díaz de Tuesta Del Arco
{"title":"Fatal septic shock and Waterhouse-Friderichsen syndrome caused by serovar B Capnocytophaga canimorsus in an immunocompetent patient. Case report and review.","authors":"D Fernández Vecilla, I Angulo López, F E Calvo Muro, C Aspichueta Vivanco, F Renzi, M E Pereda Martínez, J Rosselló Soria, J L Díaz de Tuesta Del Arco","doi":"10.37201/req/060.2022","DOIUrl":"10.37201/req/060.2022","url":null,"abstract":"Rev Esp Quimioter 2023;36(1): 92-96 92 Two sets of blood cultures were obtained before starting empiric broad-spectrum antibiotic therapy with intravenous piperacillin-tazobactam, meropenem and clindamycin (4/0,5g single dose, 2 g/8 h and 900 mg/8 h, respectively). Despite high-dose intravenous fluid replacement, noradrenaline and bicarbonate infusions, the patient didn ́t improve and was transferred to intensive care unit after orotracheal intubation. A body CT scan was conducted, which described signs of hypovolemic shock with thickening of both adrenal glands with crosslinking of the peri-renal fluid, as well as liver with periportal edema and no highlight of the spleen (Figure 2A). Her condition deteriorated rapidly overnight and, in spite of cardiopulmonary resuscitation measures, patient expired 16 hours after admission. Because of multi-organ failure and septic shock of unknown origin, an autopsy was requested.","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/ea/revespquimioter-36-092.PMC9910678.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10790924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D Fernández Vecilla, I Angulo López, M L Gurruchaga Yanes, M C Nieto Toboso, J L Díaz de Tuesta Del Arco
{"title":"Is Propionimicrobium lymphophilum a new urinary tract infection cause?","authors":"D Fernández Vecilla, I Angulo López, M L Gurruchaga Yanes, M C Nieto Toboso, J L Díaz de Tuesta Del Arco","doi":"10.37201/req/086.2022","DOIUrl":"https://doi.org/10.37201/req/086.2022","url":null,"abstract":"Propionimicrobium lymphophilum is a non-sporulating anaerobic Gram-positive bacillus belonging to the family Propionibacteriaceae and is part of the microbiota of the skin and the human urinary tract. Originally described as Bacillus lymphophilum in 1916, after several taxonomic changes, which included Corynebacterium lymphophilum and P. lymphophilum, the current nomenclature of P. lymphophilum has been adopted [1]. After reviewing the literature, five cases of infections caused by this microorganism have been published, among which only two of them corresponded to urinary tract infections (UTIs) [2-5].","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/8c/revespquimioter-36-107.PMC9910668.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10735642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N Mihic, J Abascal, J López Chicharro, F Segura, S Huurman, B Núñez de Aysa, E Bouza
{"title":"Impact and control of the COVID pandemic in an elite sports club: Real Madrid.","authors":"N Mihic, J Abascal, J López Chicharro, F Segura, S Huurman, B Núñez de Aysa, E Bouza","doi":"10.37201/req/072.2022","DOIUrl":"10.37201/req/072.2022","url":null,"abstract":"<p><p>The incidence and risk factors for poor outcome in patients with COVID are well known, as are the protective measures in high-risk populations. In contrast, the epidemiological and clinical behavior of this disease in the population of elite athletes who are the paradigm of good health is poorly understood. Data on COVID in athletes are scarce and have focused preferentially on the consequences on sports performance of confinement measures and on the pathophysiological risks of infected athletes. Real Madrid is a large elite sports institution with facilities in the City of Madrid where 600 athletes train daily. The incidence of COVID during a study period of 671 days of observation in athletes, professional or amateur, working in the institution has been 0,74 per 1,000 days of exposure. The disease has been asymptomatic or oligosymptomatic in all athletes and did not require any hospital admissions. The different teams did not have to suspend any of its sportive commitments for COVID during the study period and there was no evidence of outbreaks of internal transmission between members of the different teams.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/87/revespquimioter-36-059.PMC9910681.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9300279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M J Pérez-Granda, P Catalán, P Muñoz, T Aldámiz, J C Barrios, C Ramírez, R García-Martínez, M V Villalba, L Puente, E Bouza
{"title":"Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital.","authors":"M J Pérez-Granda, P Catalán, P Muñoz, T Aldámiz, J C Barrios, C Ramírez, R García-Martínez, M V Villalba, L Puente, E Bouza","doi":"10.37201/req/068.2022","DOIUrl":"https://doi.org/10.37201/req/068.2022","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence of CMV reactivation in a population admitted for severe COVID-19 to a general hospital.</p><p><strong>Methods: </strong>Point prevalence study in all hospitalized patients with severe COVID-19 (admitted either to general wards or ICU). Determination of the presence of CMV DNA in circulating blood. COVID-19 was confirmed in patients with compatible clinical manifestations, usually with pneumonia and a positive nasopharyngeal PCR test.</p><p><strong>Results: </strong>We included 140 hospitalized patients with COVID-19 who consented to participate. A total of 16 patients (11.42%), had circulating CMV-DNA in peripheral blood at the time of the study. Patients with positive CMV viral load were mainly ICU patients (11/37 -29,7%) and only 5/103 cases (4,85%) were hospitalized into general wards. The accumulated doses of corticosteroids (prednisone equivalents) in the study day were (median and IQR) 987.50 mg (396.87-2,454.68) and 187.50 mg (75.00-818.12) respectively in CMV positive and negative patients (p < 0.001). A significant proportion of CMV positive patients were discovered because of the study and were clinically unsuspected by their physicians. The coinfected COVID-CMV positive population had a higher risk of accumulated secondary nosocomially-acquired infections and a worse prognosis.</p><p><strong>Conclusions: </strong>CMV reactivation should be systematically searched in patients in COVID-19 cases admitted to the ICU.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/46/revespquimioter-36-045.PMC9910675.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10790915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P Retamar-Gentil, R Cantón, V Abril López de Medrano, J Barberán, A Canut Blasco, C Dueñas Gutiérrez, C García-Vidal, N Larrosa Escartín, J Lora-Tamayo, F J Martínez Marcos, C Martín Ruíz, J Pasquau Liaño, P Rascado, O Sanz Peláez, G Yagüe Girao, J P Horcajada
{"title":"Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.","authors":"P Retamar-Gentil, R Cantón, V Abril López de Medrano, J Barberán, A Canut Blasco, C Dueñas Gutiérrez, C García-Vidal, N Larrosa Escartín, J Lora-Tamayo, F J Martínez Marcos, C Martín Ruíz, J Pasquau Liaño, P Rascado, O Sanz Peláez, G Yagüe Girao, J P Horcajada","doi":"10.37201/req/119.2022","DOIUrl":"https://doi.org/10.37201/req/119.2022","url":null,"abstract":"<p><strong>Background: </strong>Antibiotic resistance in Gram-negative bacilli poses a serious problem for public health. In hospitals, in addition to high mortality rates, the emergence and spread of resistance to practically all antibiotics restricts therapeutic options against serious and frequent infections.</p><p><strong>Objective: </strong>The aim of this work is to present the views of a group of experts on the following aspects regarding resistance to antimicrobial agents in Gram-negative bacilli: 1) the current epidemiology in Spain, 2) how it is related to local clinical practice and 3) new therapies in this area, based on currently available evidence.</p><p><strong>Methods: </strong>After reviewing the most noteworthy evidence, the most relevant data on these three aspects were presented at a national meeting to 99 experts in infectious diseases, clinical microbiology, internal medicine, intensive care medicine, anaesthesiology and hospital pharmacy.</p><p><strong>Results and conclusions: </strong>Subsequent local debates among these experts led to conclusions in this matter, including the opinion that the approval of new antibiotics makes it necessary to train the specialists involved in order to optimise how they use them and improve health outcomes; microbiology laboratories in hospitals must be available throughout a continuous timetable; all antibiotics must be available when needed and it is necessary to learn to use them correctly; and the Antimicrobial Stewardship Programs (ASP) play a key role in quickly allocating the new antibiotics within the guidelines and ensure appropriate use of them.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/eb/revespquimioter-36-065.PMC9910669.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9300805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The role of hospital emergency departments in identifying patients with unknown HIV infection: an opportunity for diagnosis.","authors":"A García-Martínez, M I Carbó","doi":"10.37201/req/079.2022","DOIUrl":"https://doi.org/10.37201/req/079.2022","url":null,"abstract":"Rev Esp Quimioter 2023;36(1): 101-102 101 cess to guarantee patient continuity of care after the ED visit [5]. Based on these recommendations, the Catalan Society of Emergency Medicine (Socmue) launched the campaign called “Urgències VIHgila”. The aim of this campaign is to promote HIV screening in patients presenting to the ED with one of the following conditions or high-risk behaviours for HIV infection: sexually transmitted infections, mononucleosic syndrome, herpes zoster or community-acquired pneumonia, these last two in patients younger than 65 years of age, and finally, patients who report practice of chemsex or come to the ED asking for post-exposure prophylaxis. These six groups of conditions/scenarios are often seen in ED and are common in patients with HIV-positive tests.","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/b5/revespquimioter-36-101.PMC9910670.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10736435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus].","authors":"J Reina, C Iglesias","doi":"10.37201/req/096.2022","DOIUrl":"https://doi.org/10.37201/req/096.2022","url":null,"abstract":"<p><p>The absence of an effective vaccine against respiratory syncytial virus (RSV) has led to the development of various drugs with the ability to inhibit or block its replicative activity. The first generation, called fusion inhibitors, bind to the protein on the viral surface and prevent the virus from binding and entering the cell. However, its low efficacy has determined the start of studies with second-generation compounds capable of binding or blocking the nucleoprotein (N); most of these compounds are analogs of 1,4-benzodiazepines. EDP-938 has shown high efficacy against RSV. The first trials in humans have shown that this antiviral is rapidly absorbed after oral administration and has a half-life of between 11-18 hours Administration for seven days of multiple oral doses of up to 600 mg/day or 300 mg/day/twice a day, there were hardly any significant adverse effects and the viral load in the lower respiratory tract decreased significantly.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/e3/revespquimioter-36-026.PMC9910671.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10749600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P García-Lloret, Y Borrego-Izquierdo, M Manzano-García, M G Cantillana-Suárez, A Gutiérrez-Pizarraya, R Morillo-Verdugo
{"title":"Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project.","authors":"P García-Lloret, Y Borrego-Izquierdo, M Manzano-García, M G Cantillana-Suárez, A Gutiérrez-Pizarraya, R Morillo-Verdugo","doi":"10.37201/req/070.2022","DOIUrl":"https://doi.org/10.37201/req/070.2022","url":null,"abstract":"<p><strong>Objective: </strong>The objective is to determine the prevalence of potentially inappropriate drugs according to the Marc, STOPP, and PRISCUS lists in elderly HIV patients.</p><p><strong>Methods: </strong>It was an observational, retrospective, and multicenter study. People living with HIV 65 years or older who underwent chronic concomitant treatment were included. Descriptive and multivariate analyzes were performed to study the association between polypharmacy and potentially inappropriate medication compliance.</p><p><strong>Results: </strong>A total of 55 patients were included, 81.8% men and a median age of 69 years (IQR: 67-73). The median number of comorbidities was 3 (IQR: 2-5) and the most frequent pattern of multimorbidity was cardiometabolic (62.9%). The predominant antiretroviral treatment was triple therapy (65.5%). Polypharmacy was present in 70.9% of the patients and 25.5% had major polypharmacy. The most frequent polypharmacy pattern was cardiovascular (69.2%). The percentage of potentially inappropriate medications according to the Marc, STOPP and PRISCUS lists was 65.5%, 30.9% and 14.5%, respectively (p<0.001). Adjusted for age and sex, polypharmacy was not independently associated with potentially inappropriate medication compliance in any of the lists.</p><p><strong>Conclusions: </strong>Polypharmacy and potentially inappropriate medications have a high prevalence. There is great variability in the percentage according to the list applied. Age, sex, and presence of polypharmacy are not predisposing factors to the presence of potentially inappropriate medications.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/be/revespquimioter-36-052.PMC9910679.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10723841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}